Residents practicing delivering teaching scripts and getting feedback from peers & Med Studs. Part of our Resident As Teachers curriculum #WhyUmichIM @UM_IntMedCMRs @atessa91 @CatMcDe1 @UMIMEqualMed

This x 💯. It also reminds me how much #RepresentationMatters in leadership positions. Having a passionate physician and mother like @ginny_sheffield as a chief resident has led to numerous progressive policies supporting resident parents. #WhyUMichIM U-M Department of Internal Medicine @UMIMEqualMed

Inspiring talk by Payal K. Patel for our PGY2 residents at their annual retreat. Keys to success for tackling your resident research project. @UM_IntMedCMRs UMich Med Peds

Beyond excited to continue my training Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center as a Med Onc fellow! I am eternally grateful to my family and all of the incredible mentors who have supported me along the way.

NEW: A NEJM research letter by a team of our members & colleagues suggests skin color can affect #pulseox readings, which are used to guide admission & treatment decisions for #COVID19 and more: ihpi.umich.edu/news/racially-… #HealthDisparities

Awesome case, Paul Christine ! We mustache you some questions about your grooming choices tho... @UM_IntMedCMRs

The deadline for applications is May 31, 2021. Please visit the following link for further details about how to apply: drive.google.com/file/d/1Wvi_lp… You can also DM me for more details. Rita Redberg Tanner Caverly @GovindWarrierMD Raymond Y. Yeow

Highly recommend this opportunity for those interested in learning more about the editorial process and building independent review skills! All thanks to incredible mentorship from the JAMA IM editorial staff Deborah Grady Tanner Caverly Rita Redberg !

Sine 2013, my Johns Hopkins Medicine team and I have led development of a new #Immunotherapy, which was approved today by FDA for advanced #Melanoma onclive.com/view/fda-appro… via @onclive

New Research: Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab: Background Standard combination ipilimumab/nivolumab (I/N) is given as 4 induction doses for advanced stage melanoma followed… frontiersin.org/articles/10.33… #immunology

So excited for this opportunity to serve, learn, and innovate with the best people Johns Hopkins Hematology and Oncology Fellowship ! Kristen A. Marrone, MD B Douglas Smith Rakhi Naik, MD MHS @saumarai Johns Hopkins Kimmel Cancer Center

A true privilege to lead this effort highlighting the benefits of palliative care for our patients - made possible through incredible support from Ramy Sedhom, MD, FASCO, Arjun Gupta, and @MInczeMD. We hope our work can serve to guide, and advance care, for patients and their families.

Join 1104Health for their webinar titled " Understanding your Melanoma Diagnosis." This will feature Dr. Govind Warrier from the Johns Hopkins University Melanoma Program discussing the breakdown of your diagnosis, how treatments are considered and more - buff.ly/3VGDoGz

WATCH LIVE IN 1 HOUR ➡️ ms.spr.ly/6013mfc3c 🔑 Unlock these immunotherapy updates for melanoma, HCC, and lung cancer! bet9 优德体育 足球 速8体育 彩金 江山美景图 彩娱乐 AB视讯 + Govind Warrier MD, MPH will discuss the possible impact on clinical practice to make more informed decisions for patients.

Your loved one has cancer—what does this mean for you? This JAMA Internal Medicine Patient Page describes the role and challenges of caring for a loved one with cancer. Govind Warrier MD, MPH ja.ma/4jzmkO3

From JAMA Internal Medicine: Your loved one has cancer—what does this mean for you? This JAMA Internal Medicine Patient Page describes the role and challenges of caring for a loved one with cancer. Govind Warrier MD, MPH ja.ma/3PXx4rV